Folliculitis News and Research

RSS
Can synthetic data boost fairness in medical imaging AI?

Can synthetic data boost fairness in medical imaging AI?

Did COVID-19 mitigation measures in the United Kingdom impact the transmission of other infectious diseases?

Did COVID-19 mitigation measures in the United Kingdom impact the transmission of other infectious diseases?

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

Skin disorders on the rise during COVID‐19 pandemic due to infection and PPE use

Skin disorders on the rise during COVID‐19 pandemic due to infection and PPE use

Research finds rising trend in incidence of merkel cell carcinoma

Research finds rising trend in incidence of merkel cell carcinoma

LEO Pharma's Enstilar gets FDA approval for topical treatment of plaque psoriasis

LEO Pharma's Enstilar gets FDA approval for topical treatment of plaque psoriasis

Valeant receives FDA approval for secondary supplier of Methoxsalen

Valeant receives FDA approval for secondary supplier of Methoxsalen

LEO Pharma introduces new Taclonex website for plaque psoriasis treatment

LEO Pharma introduces new Taclonex website for plaque psoriasis treatment

Valeant, Promius sign deal to market Cloderm Cream

Valeant, Promius sign deal to market Cloderm Cream

Results of Phase 2 rheumatoid arthritis clinical trial announced

Results of Phase 2 rheumatoid arthritis clinical trial announced

Post hurricane skin disorders in clean up workers

Post hurricane skin disorders in clean up workers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.